Abstract
Human serum, obtained from a patient with Graves’s disease and containing a high level of long-acting thyroid stimulator, elicited highly significant responses when injected into hypophysectomized mice. The mean response did not differ significantly from that elicited in a control group of intact mice. This shows that the site of action of the abnormal thyroid stimulator is not the pituitary gland and makes it likely that the material acts directly on the thyroid.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
